Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ascani

Showing results (341-350 of 361) with videos related to

Pageof 37
Sort By:
The New England Journal of Medicine|May 12, 2021
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell LeukemiaEnrico Tiacci, Luca De Carolis, Edoardo Simonetti, et al.
Leukemia|December 16, 2006
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patientsS A Pileri, S Ascani, M C Cox, et al.
Kidney International|January 20, 2024
Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, todayHoward Trachtman, Hailey Desmond, Amanda L Williams, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 6, 2021
A Participant-Centered Approach to Understanding Risks and Benefits of Participation in Research Informed by the Kidney Precision Medicine ProjectCatherine R Butler, Paul S Appelbaum, Heather Ascani, et al.
Cancers|December 10, 2021
EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3)Magda Zanelli, Francesca Sanguedolce, Andrea Palicelli, et al.
Haematologica|June 29, 2023
Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: a novel regulator of mitophagy in T-cell lymphomaValentina Mularoni, Benedetta Donati, Annalisa Tameni, et al.
Blood|April 14, 2018
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphomaEnrico Tiacci, Erik Ladewig, Gianluca Schiavoni, et al.
Biomedicines|February 25, 2022
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, <i>BRCA</i>, <i>PTEN</i>, and Other GenesAndrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
Haematologica|May 10, 2007
Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regionsAndrés J M Ferreri, Giuseppina P Dognini, Elías Campo, et al.
International Journal of Molecular Sciences|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models)Andrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
Pageof 37

Showing results (341-350 of 361) with videos related to

Sort By:
Pageof 37
The New England Journal of Medicine|May 12, 2021
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell LeukemiaEnrico Tiacci, Luca De Carolis, Edoardo Simonetti, et al.
Leukemia|December 16, 2006
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patientsS A Pileri, S Ascani, M C Cox, et al.
Kidney International|January 20, 2024
Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, todayHoward Trachtman, Hailey Desmond, Amanda L Williams, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 6, 2021
A Participant-Centered Approach to Understanding Risks and Benefits of Participation in Research Informed by the Kidney Precision Medicine ProjectCatherine R Butler, Paul S Appelbaum, Heather Ascani, et al.
Cancers|December 10, 2021
EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3)Magda Zanelli, Francesca Sanguedolce, Andrea Palicelli, et al.
Haematologica|June 29, 2023
Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: a novel regulator of mitophagy in T-cell lymphomaValentina Mularoni, Benedetta Donati, Annalisa Tameni, et al.
Blood|April 14, 2018
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphomaEnrico Tiacci, Erik Ladewig, Gianluca Schiavoni, et al.
Biomedicines|February 25, 2022
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, <i>BRCA</i>, <i>PTEN</i>, and Other GenesAndrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
Haematologica|May 10, 2007
Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regionsAndrés J M Ferreri, Giuseppina P Dognini, Elías Campo, et al.
International Journal of Molecular Sciences|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models)Andrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
Pageof 37